Search results
Feb 1, 2023 · The Trade: Precigen, Inc. (NASDAQ:PGEN) Director Randal J Kirk bought a total of 11,428,571 shares at an average price of $1.75. To acquire these shares, it cost around $20 million ....
- Lisa Levin
Current 13D/G Holdings. Detailed Profile of KIRK RANDAL J portfolio of holdings. SEC Filings include 13F quarterly reports, 13D/G events and more.
May 4, 2024 · The estimated Net Worth of Randal J Kirk is at least $131 Million dollars as of 9 March 2024. Mr. Kirk owns over 213,675 units of Precigen Inc stock worth over $40,705,355 and over the last 17 years he sold PGEN stock worth over $88,624,666. In addition, he makes $2,067,620 as Executive Chairman of the Board at Precigen Inc.
Randal J. Kirk, Chairman and Senior Managing Director of Third Security, LLC, an investment management firm founded by Mr. Kirk. Additionally, Mr. Kirk founded and became Chairman of the Board of New River Pharmaceuticals Inc. (previously traded on NASDAQ prior to its acquisition by Shire plc in 2007) in 1996, and was President and Chief ...
Mr. Kirk provides a wealth of strategic, operational and management experience. Mr. Kirk currently serves as the Senior Managing Director and Chief Executive Officer of Third Security, LLC, an investment management firm founded by Mr. Kirk in March 1999.
Randal J. Kirk stock holdings and net worth Randal J. Kirk (born March 1, 1954) is an American businessman and investor in pharmaceuticals and biotechnology. Kirk was the chairman and chief executive officer of Intrexon (NYSE: XON), a biotechnology company, until 2020.
Jun 4, 2019 · The price of the stock has increased by 11.73% since. CEO, 10% Owner Randal J Kirk bought 410,050 shares of XON stock on 05/24/2019 at the average price of $4.69. For the complete insider...
